News & Videos - US NASDAQ Stocks - English

Data confirmed TX45’s tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”) In new echocardiographic analysis, TX45 treatment resulted in sustained hemodynamic effects for 29 days TX45 improved cardiac and pulmonary hemodynamics in PH-HFpEF patients across a range of left ventricular ejection fractions (“LVEF”), including LVEF≥50% and...

Data suggests that single dose of RJVA-001 leads to durable metabolic improvements with low systemic GLP-1 exposure in db/db mouse model of T2D — potentially simultaneously addressing durability, adherence, and tolerability challenges seen with current GLP-1 drugs Endoscopic ultrasound-guided delivery achieves targeted pancreatic expression in a large animal model with no toxicity observed to date Data show nutrient-responsive GLP-1 secretion in human beta cells and human islets, demonstrating...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today presented the most contemporary analysis of the HELIOS-B Phase 3 study of vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) as a late-breaking abstract at the Heart Failure 2025 Congress, a scientific congress of the European Society of Cardiology, taking place May 17-20 in Belgrade, Serbia. The results demonstrate that vutrisiran, which rapidly knocks down transthyretin,...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of NV5 Global , Inc. (NasdaqGS: NVEE) to Acuren Corporation (NYSE: TIC). Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren, subject to adjustment. KSF is seeking to determine whether this consideration and the...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Charter Communications , Inc. (NasdaqGS: CHTR) and Cox Communications. Upon closing of the proposed transaction, Cox Enterprises will own approximately 23% of the combined entity's fully diluted shares outstanding, on an as-converted, as-exchanged basis, and pro forma for the closing of the Liberty Broadband merger. KSF is seeking to...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company’s previously announced $16 million offering that was announced on May 15, 2025. The offering closed on May 16, 2025. Mr....

RIVERSIDE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- SolarMax Technology, Inc. (Nasdaq SMXT) (“SolarMax” or the “Company”), an integrated solar energy company, today reported financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue: $6.9 million, compared with $5.8 million in the first quarter of 2024. Gross profit: $1.4 million, compared with ($0.5) million in the first quarter of 2024. Cost of revenues in the first quarter of 2024 included...

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Capricor announced on May 5, 2025, that following "the completion of a mid-cycle review...

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 PR Newswire WASHINGTON, May 16, 2025 WASHINGTON , May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025 . About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development...

SCOTTSDALE, Ariz., May 16, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that on May 16, 2025, it received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) which requires that companies listed on Nasdaq maintain a minimum bid price of $1.00 per share. As previously disclosed, on May 14, 2024, the...

WUXI, China, May 16, 2025 (GLOBE NEWSWIRE) -- LOBO EV TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”) today announced that it received a notification letter dated May 13, 2025 from the Nasdaq Stock Market LLC (“Nasdaq”), indicating that the Company is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. According to the letter, the closing bid price of the Company’s...

CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, May 16, 2025 NEW YORK , May 16, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025 , both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve...

Securities Fraud Investigation Into Landstar System, Inc. (LSTR) Continues - Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm PR Newswire LOS ANGELES, May 16, 2025 LOS ANGELES , May 16, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Landstar System, Inc. ("Landstar" or the "Company") (NASDAQ: LSTR ) investors concerning the Company's possible...

Fort Lee, NJ, May 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the 3rd Annual H.C. Wainwright Global BioConnect Investor Conference. Event 3rd Annual H.C. Wainwright BioConnect...

NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC (“RP Management”). The acquisition received overwhelming support from Royalty Pharma’s shareholders, with 99.9% of votes cast in favor of the transaction. “The completion of the internalization marks an exciting new chapter for Royalty Pharma,” said Pablo Legorreta, founder and Chief Executive Officer....

Landstar System, Inc. (LSTR) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation PR Newswire BENSALEM, Pa., May 16, 2025 BENSALEM, Pa. , May 16, 2025 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Landstar System, Inc. ("Landstar" or the "Company") (NASDAQ: LSTR ) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LANDSTAR...

Landstar System, Inc. (LSTR) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation PR Newswire BENSALEM, Pa., May 16, 2025 BENSALEM, Pa. , May 16, 2025 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Landstar System, Inc. ("Landstar" or the "Company") (NASDAQ: LSTR ) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LANDSTAR...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 94,050 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committee. The inducement...

As previously announced on May 14, 2025, Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), have amended their definitive agreement pursuant to which Carlyle and SK Capital will purchase all of the outstanding shares of bluebird. The parties have issued the following updated instructions for stockholders to tender their shares into the offer. Updated Instructions for Stockholders: Contrary to prior...

Securities Fraud Investigation Into Landstar System, Inc. (LSTR) Continues - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz PR Newswire LOS ANGELES, May 16, 2025 LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of Landstar System, Inc. ("Landstar" or the "Company") (NASDAQ: LSTR ) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY...